The CpG-sites of the CBX3 ubiquitous chromatin opening element are critical structural determinants for the anti-silencing function
Abstract Suppression of therapeutic transgene expression from retroviral gene therapy vectors by epigenetic defence mechanisms represents a problem that is particularly encountered in pluripotent stem cells (PSCs) and their differentiated progeny. Transgene expression in these cells, however, can be...
Enregistré dans:
Auteurs principaux: | Jessica Kunkiel, Natascha Gödecke, Mania Ackermann, Dirk Hoffmann, Axel Schambach, Nico Lachmann, Dagmar Wirth, Thomas Moritz |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/39b1333cdd3f49e5b6f13a3b49b6f0d6 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Low biological fluctuation of mitochondrial CpG and non-CpG methylation at the single-molecule level
par: Chloe Goldsmith, et autres
Publié: (2021) -
CpG-Based Nanovaccines for Cancer Immunotherapy
par: Chen W, et autres
Publié: (2021) -
Centromere evolution and CpG methylation during vertebrate speciation
par: Kazuki Ichikawa, et autres
Publié: (2017) -
Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system
par: Hanagata N
Publié: (2012) -
A CpG island promoter drives the CXXC5 gene expression
par: Pelin Yaşar, et autres
Publié: (2021)